02 February 2012
Swedish medtech firm Getinge beat analysts' estimates in its fourth fiscal quarter due to "strong margin improvements", according to Jefferies analyst Ingeborg Øie. Q4 net sales were up 11% to SEK7.35bn ($1.09bn), while net income also increased to ...
02 February 2012
Smith & Nephew beat its trading profit margin target in the fourth quarter of 2011, thanks largely to the company's efforts to curb costs and create a more streamlined organisation.
The firm reported trading profit of $279m in Q4, on the back of a ...
01 February 2012
CR Bard has seen its bottom line shrink 16% to $113.8m during its fourth fiscal quarter as it absorbed charges relating to acquisitions, as well as restructuring and legal fees. Q4 net sales were up 5% year-on-year to $751.9m, with a stronger ...
27 January 2012
Baxter International posted solid fourth-quarter results, with worldwide group revenue rising 3% to $3.59bn. The firm's medical products division grew 3% to $2.01bn, while sales in its other division, bioscience, also went up 3% to $1.58bn.
Group ...
26 January 2012
Abbott is "setting up well for 2012" with guidance for the year ahead "largely encouraging", according to Morgan Stanley analyst David Lewis. The firm is predicting earnings of $4.95-5.05 for full-year 2012, within Wall Street consensus expectations ...
